What is Kernel?
Kernel is a pioneering neurotechnology firm dedicated to advancing brain health through accessible, evidence-based measurements. By integrating non-invasive brain scanning hardware with sophisticated analytical algorithms, the company provides granular insights into cognitive function. Its core offerings, including Brain Age and cognitive tracking tools, are designed to serve both the wellness market and clinical environments. By enabling healthcare professionals to utilize Kernel Scans, the company aims to improve patient outcomes and enhance treatment efficacy for neurological conditions such as depression. Kernel operates at the intersection of biotechnology and data science, positioning itself as a leader in the emerging field of quantitative neuroscience.
How much funding has Kernel raised?
Kernel has raised a total of $53M across 1 funding round:
Series C
$53M
Series C (2020): $53M with participation from Manta Ray Ventures, General Catalyst, Khosla Ventures, Eldridge, Bryan Johnson, and Tiny Blue Dot
Key Investors in Kernel
General Catalyst
General Catalyst is a venture capital firm that supports transformational business opportunities across multiple sectors, leveraging deep operational expertise to help founders scale enduring enterprises.
Khosla Ventures
Khosla Ventures provides strategic assistance to entrepreneurs developing breakthrough technologies, with a focus on sectors including health, AI, and sustainable energy.
Manta Ray Ventures
Manta Ray Ventures is an investment firm that focuses on backing early-to-growth stage companies that leverage technology to solve complex, large-scale problems.
What's next for Kernel?
With this major strategic investment, Kernel is poised to scale its operations and expand its footprint within the clinical healthcare market. The company's roadmap likely involves deepening its research partnerships to validate its technology across a wider array of medical conditions while simultaneously refining its hardware for broader commercial adoption. As Kernel continues to build its infrastructure, the focus will shift toward establishing long-term clinical utility and integrating its cognitive data platforms into standard medical workflows. This phase of development is essential for the company to solidify its market position as a foundational provider of brain health analytics, ultimately aiming to transform how cognitive health is monitored and managed on a global scale.
See full Kernel company page
